Deutsche Bank’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.56M Buy
24,401
+3,878
+19% +$269K ﹤0.01% 1925
2025
Q4
$1.63M Buy
20,523
+1,637
+9% +$138K ﹤0.01% 1913
2025
Q3
$1.25M Buy
18,886
+2,169
+13% +$129K ﹤0.01% 2039
2025
Q2
$885K Buy
16,717
+2,012
+14% +$94.5K ﹤0.01% 2161
2025
Q1
$730K Sell
14,705
-1,388
-9% -$77.2K ﹤0.01% 2303
2024
Q4
$1.02M Buy
16,093
+6,933
+76% +$401K ﹤0.01% 2220
2024
Q3
$450K Buy
9,160
+2,347
+34% +$110K ﹤0.01% 2516
2024
Q2
$307K Buy
6,813
+2,167
+47% +$73.6K ﹤0.01% 2585
2024
Q1
$289K Buy
4,646
+124
+3% +$8.04K ﹤0.01% 2630
2023
Q4
$261K Sell
4,522
-87
-2% -$4.46K ﹤0.01% 2728
2023
Q3
$217K Buy
4,609
+987
+27% +$49.4K ﹤0.01% 2731
2023
Q2
$161K Buy
+3,622
New +$129K ﹤0.01% 3016
2022
Q2
Sell
-396
Closed -$17K 4222
2022
Q1
$17K Sell
396
-1,421
-78% -$74.5K ﹤0.01% 4072
2021
Q4
$159K Buy
1,817
+23
+1% +$2.25K ﹤0.01% 3489
2021
Q3
$217K Sell
1,794
-13
-0.7% -$1.78K ﹤0.01% 3526
2021
Q2
$351K Buy
1,807
+433
+32% +$142K ﹤0.01% 3453
2021
Q1
$558K Buy
+1,374
New +$613K ﹤0.01% 3033

Other funds holding IRON

Deutsche Bank's IRON Position: Q1 2026 in Review

Deutsche Bank increased its Disc Medicine (IRON) stake by 19% in Q1 2026, buying an estimated $269K and bringing the position to 24,401 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1925.

Deutsche Bank first reported a position in IRON in Q1 2021 and has held it in 17 quarters since. The position peaked at $1.63M in Q4 2025. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Deutsche Bank held 24,401 shares of Disc Medicine worth $1.56M as of Q1 2026.
  • Deutsche Bank bought 3,878 Disc Medicine shares in Q1 2026, an estimated $269K.
  • Disc Medicine made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #1925 holding.
  • Deutsche Bank first reported a position in Disc Medicine in Q1 2021 and has held it in 17 quarters since.
  • Deutsche Bank's Disc Medicine position peaked at $1.63M in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.